The emerging treatment of this peptide represents a significant development in the care of diabetes mellitus type 2. Different to existing medications, tirzepatide targets two pathways – GLP-1 and glucose-dependent https://tirzepatidepeptide922119.slypage.com/42578139/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment